These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 20462898)
1. Review of the role of erythropoietin in critical leg ischemia. Joshi D; Tsui J; Ho TK; Selvakumar S; Abraham DJ; Baker DM Angiology; 2010 Aug; 61(6):541-50. PubMed ID: 20462898 [TBL] [Abstract][Full Text] [Related]
2. Erythropoietin reduces necrosis in critically ischemic myocutaneous tissue by protecting nutritive perfusion in a dose-dependent manner. Harder Y; Amon M; Schramm R; Contaldo C; Metzkow E; Matzen A; Rücker M; Vollmar B; Menger MD Surgery; 2009 Apr; 145(4):372-83. PubMed ID: 19303985 [TBL] [Abstract][Full Text] [Related]
3. Sustained release of erythropoietin using biodegradable gelatin hydrogel microspheres persistently improves lower leg ischemia. Li L; Okada H; Takemura G; Esaki M; Kobayashi H; Kanamori H; Kawamura I; Maruyama R; Fujiwara T; Fujiwara H; Tabata Y; Minatoguchi S J Am Coll Cardiol; 2009 Jun; 53(25):2378-88. PubMed ID: 19539150 [TBL] [Abstract][Full Text] [Related]
4. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway. Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734 [TBL] [Abstract][Full Text] [Related]
6. Erythropoietin enhances the angiogenic potency of autologous bone marrow stromal cells in a rat model of myocardial infarction. Zhang D; Zhang F; Zhang Y; Gao X; Li C; Ma W; Cao K Cardiology; 2007; 108(4):228-36. PubMed ID: 17106196 [TBL] [Abstract][Full Text] [Related]
7. Carbamylated darbepoetin derivative prevents endothelial progenitor cell damage with no effect on angiogenesis. Ramirez R; Carracedo J; Nogueras S; Buendia P; Merino A; Cañadillas S; Rodríguez M; Tetta C; Martin-Malo A; Aljama P J Mol Cell Cardiol; 2009 Dec; 47(6):781-8. PubMed ID: 19782086 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits. Hershey JC; Baskin EP; Corcoran HA; Bett A; Dougherty NM; Gilberto DB; Mao X; Thomas KA; Cook JJ Heart Vessels; 2003 Jul; 18(3):142-9. PubMed ID: 12955430 [TBL] [Abstract][Full Text] [Related]
9. Erythroid cells play essential roles in angiogenesis by bone marrow cell implantation. Ozawa T; Toba K; Kato K; Minagawa S; Saigawa T; Hanawa H; Makiyama Y; Moriyama M; Honma K; Isoda M; Hasegawa G; Naito M; Takahashi M; Aizawa Y J Mol Cell Cardiol; 2006 May; 40(5):629-38. PubMed ID: 16603182 [TBL] [Abstract][Full Text] [Related]
10. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. van Weel V; van Tongeren RB; van Hinsbergh VW; van Bockel JH; Quax PH Ann Vasc Surg; 2008; 22(4):582-97. PubMed ID: 18504100 [TBL] [Abstract][Full Text] [Related]
11. Direct implantations of erythropoietin and autologous EPCs in critical limb ischemia (CLI) area restored CLI area blood flow and rescued remote AMI-induced LV dysfunction. Lee FY; Luo CW; Wallace CG; Chen KH; Sheu JJ; Yin TC; Chai HT; Yip HK Biomed Pharmacother; 2019 Oct; 118():109296. PubMed ID: 31545254 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of erythropoietin in cardiac ischemia: from bench to bedside. Lipsic E; Schoemaker RG; van der Meer P; Voors AA; van Veldhuisen DJ; van Gilst WH J Am Coll Cardiol; 2006 Dec; 48(11):2161-7. PubMed ID: 17161240 [TBL] [Abstract][Full Text] [Related]
13. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells. Zwezdaryk KJ; Coffelt SB; Figueroa YG; Liu J; Phinney DG; LaMarca HL; Florez L; Morris CB; Hoyle GW; Scandurro AB Exp Hematol; 2007 Apr; 35(4):640-52. PubMed ID: 17379074 [TBL] [Abstract][Full Text] [Related]
14. [Stimulated angiogenesis: a new trend in the treatment of ischemic conditions]. Davydenko VV; Machs VM Vestn Khir Im I I Grek; 2000; 159(1):117-20. PubMed ID: 10890120 [No Abstract] [Full Text] [Related]
15. Potential role of erythropoietin receptors and ligands in attenuating apoptosis and inflammation in critical limb ischemia. Joshi D; Abraham D; Shiwen X; Baker D; Tsui J J Vasc Surg; 2014 Jul; 60(1):191-201, 201.e1-2. PubMed ID: 24055514 [TBL] [Abstract][Full Text] [Related]
16. Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia. Ruifrok WP; de Boer RA; Iwakura A; Silver M; Kusano K; Tio RA; Losordo DW Vasc Med; 2009 Feb; 14(1):29-36. PubMed ID: 19144777 [TBL] [Abstract][Full Text] [Related]
17. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. Li Y; Lu Z; Keogh CL; Yu SP; Wei L J Cereb Blood Flow Metab; 2007 May; 27(5):1043-54. PubMed ID: 17077815 [TBL] [Abstract][Full Text] [Related]
18. Effects of gene delivery on collateral development in chronic hypoperfusion: diverse effects of angiopoietin-1 versus vascular endothelial growth factor. Zhou YF; Stabile E; Walker J; Shou M; Baffour R; Yu Z; Rott D; Yancopoulos GD; Rudge JS; Epstein SE J Am Coll Cardiol; 2004 Aug; 44(4):897-903. PubMed ID: 15312878 [TBL] [Abstract][Full Text] [Related]
19. Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Jelkmann W; Wagner K Ann Hematol; 2004 Nov; 83(11):673-86. PubMed ID: 15322761 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium. Kubo M; Egashira K; Inoue T; Koga J; Oda S; Chen L; Nakano K; Matoba T; Kawashima Y; Hara K; Tsujimoto H; Sueishi K; Tominaga R; Sunagawa K Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):796-801. PubMed ID: 19325146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]